FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III

BACKGROUND: Immunotherapies may prolong the survival of patients with small-cell lung cancer (SCLC) to some extent. The role of forkhead box protein P3 (FOXP3) in tumor microenvironment (TME) remains controversial. We aimed to examine FOXP3-related expression characteristics and prognostic values an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Jiang, Minlin, Wu, Chunyan, Zhang, Liping, Sun, Chenglong, Wang, Hao, Xu, Yi, Sun, Hui, Zhu, Jun, Zhao, Wencheng, Fang, Qiyu, Yu, Jia, Chen, Peixin, Wu, Shengyu, Zheng, Zixuan, He, Yayi, Zhou, Caicun
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2021
Témata:
Immunotherapy Biomarkers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137193/
https://ncbi.nlm.nih.gov/pubmed/34006632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002339
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky